Denali raises $250M in IPO

Denali Therapeutics Inc. (NASDAQ:DNLI) raised $250 million through the sale of 13.9 million shares at $18 in an IPO. Underwriters were Goldman Sachs, Morgan Stanley, JPMorgan and

Read the full 275 word article

User Sign In